LeMaitre Vascular
LMAT
$53.93
Share price
0.90%
Change (1 day)
0.33%
Change (1 year)
Categories
LeMaitre Vascular (LMAT) - Total debt
Total debt on the balance sheet as of June 2023 : $16.8 M
According to LeMaitre Vascular's latest financial reports the company's total debt is $16.8 M. A company’s total debt is the sum of all current and non-current debts.
LeMaitre Vascular - Total debt on balance sheet (from 2004 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $16.59 M | 4.14% |
| 2021-12-31 | $15.93 M | -70.91% |
| 2020-12-31 | $54.77 M | 248.63% |
| 2019-12-31 | $15.71 M | |
| 2009-12-31 | $0.18 M | 141.03% |
| 2008-12-31 | $0.07 M | -74.34% |
| 2007-12-31 | $0.3 M | 850% |
| 2006-12-31 | $0.03 M | -98.32% |
| 2005-12-31 | $1.9 M | 18.42% |
| 2004-12-31 | $1.61 M | |
| 2002-12-31 | $0.93 M | 39.1% |
| 2001-12-31 | $0.67 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $16.92 B | 100,578.29% | 🇺🇸 USA |
 Boston Scientific BSX | $9.36 B | 55,620.83% | 🇺🇸 USA |
 Edwards Lifesciences EW | $0.68 B | 3,972.71% | 🇺🇸 USA |
 Teleflex TFX | $1.67 B | 9,838.72% | 🇺🇸 USA |
 AngioDynamics ANGO | $49.81 M | 196.41% | 🇺🇸 USA |
 Cardiovascular Systems CSII | $20.11 M | 19.69% | 🇺🇸 USA |